Study title and authors:
Risk of stomach cancer in association with serum cholesterol and beta-lipoprotein.
Törnberg SA, Carstensen JM, Holm LE.
Department of General Oncology, Karolinska Sjukhuset, Stockholm, Sweden.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/3365353
Department of General Oncology, Karolinska Sjukhuset, Stockholm, Sweden.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/3365353
Beta-lipoprotein equates to low-density lipoprotein (LDL) cholesterol.
This study investigated the relationship between cholesterol levels, beta-lipoprotein levels and the risk of stomach cancer. The study included 92,710 individuals who were followed for 18 years.
The study found:
(a) For every 40 mg/dL (1.03 mmol/L) increase in cholesterol there was a 15% reduced risk of stomach cancer.
(b) Increased levels of beta-lipoprotein were associated with a decreased risk of stomach cancer.
The results of the study show that higher levels of cholesterol are associated with a reduced risk of stomach cancer.
0 comments:
Post a Comment